Paper3288697
Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using beta 2-microglobulin-transfected Daudi cells.
Quillet A and 6 others. J Immunol, 1988. Cited by 138 papers, by iCite.
Cite this record
ConductScience Library. Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using beta 2-microglobulin-transfected Daudi cells. Papers, record 3288697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3288697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using beta 2-microglobulin-transfected Daudi cells.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HLA Antigens | Major topic |
| Transfection | Major topic |
| Tumor Cells, Cultured | Major topic |
| beta 2-Microglobulin | Major topic |
| Cytotoxicity, Immunologic | |
| Gene Conversion | |
| HLA-A Antigens | |
| HLA-B Antigens | |
| Humans | |
| Immunity, Innate | |
| Killer Cells, Natural |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23269923 | Ligand specificity of Killer cell Immunoglobulin-like Receptors: a brief history of KIR. | Front Immunol | 2012 | https://conductscience.org/library/papers/23269923 | PubMed |
| 21475006 | StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial. | Ann Surg | 2011 | https://conductscience.org/library/papers/21475006 | PubMed |
| 11752154 | GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization. | J Virol | 2002 | https://conductscience.org/library/papers/11752154 | PubMed |
| 11044108 | Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway. | J Virol | 2000 | https://conductscience.org/library/papers/11044108 | PubMed |
| 10590089 | Adenovirus type 37 uses sialic acid as a cellular receptor. | J Virol | 2000 | https://conductscience.org/library/papers/10590089 | PubMed |
| 10196358 | The human HLA-A*0201 allele, expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiber. | J Virol | 1999 | https://conductscience.org/library/papers/10196358 | PubMed |
| 9708194 | Fetal natural killer cell function is suppressed. | Immunology | 1998 | https://conductscience.org/library/papers/9708194 | PubMed |
| 9177157 | The mother-child union: the case of missing-self and protection of the fetus. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9177157 | PubMed |
| 9171344 | Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. | EMBO J | 1997 | https://conductscience.org/library/papers/9171344 | PubMed |
| 8876216 | The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8876216 | PubMed |
| 8162614 | Lysis of endothelial cells by autologous lymphokine-activated killer cells. | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/8162614 | PubMed |
| 7724519 | Natural killer cell receptors specific for major histocompatibility complex class I molecules. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7724519 | PubMed |
| 7722455 | Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice. | J Exp Med | 1995 | https://conductscience.org/library/papers/7722455 | PubMed |
| 2784569 | Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2784569 | PubMed |
| 2505957 | Cytotoxic activity of interleukin-2 (IL-2) activated killer cells toward thyroid epithelial cells. | Clin Exp Immunol | 1989 | https://conductscience.org/library/papers/2505957 | PubMed |
| 2307936 | Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta. | J Exp Med | 1990 | https://conductscience.org/library/papers/2307936 | PubMed |
| 2089075 | Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice. | Immunol Res | 1990 | https://conductscience.org/library/papers/2089075 | PubMed |
| 1905328 | Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene. | J Clin Invest | 1991 | https://conductscience.org/library/papers/1905328 | PubMed |
| 1898655 | Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. | J Clin Invest | 1991 | https://conductscience.org/library/papers/1898655 | PubMed |
| 1431422 | Histocompatibility antigens and natural killer susceptibility. | Immunol Res | 1992 | https://conductscience.org/library/papers/1431422 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| B2M | 567 | PubTator's text mining | https://conductscience.org/library/genes/567 | NCBI Gene |
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| HLA-B | 3106 | PubTator's text mining | https://conductscience.org/library/genes/3106 | NCBI Gene |
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 | NCBI Gene |
| HLA-G | 3135 | PubTator's text mining | https://conductscience.org/library/genes/3135 | NCBI Gene |
| IGKV3D-20 | 28874 | PubTator's text mining | https://conductscience.org/library/genes/28874 | NCBI Gene |
| NDUFB6 | 4712 | PubTator's text mining | https://conductscience.org/library/genes/4712 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3288697
GET https://conductscience.org/api/papers/v1/3288697/cited_by?page=2